Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOCLOPRAMIDE Cause Intentional product misuse? 81 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Intentional product misuse have been filed in association with METOCLOPRAMIDE (metoclopramide hydrochloride). This represents 0.7% of all adverse event reports for METOCLOPRAMIDE.

81
Reports of Intentional product misuse with METOCLOPRAMIDE
0.7%
of all METOCLOPRAMIDE reports
27
Deaths
20
Hospitalizations

How Dangerous Is Intentional product misuse From METOCLOPRAMIDE?

Of the 81 reports, 27 (33.3%) resulted in death, 20 (24.7%) required hospitalization, and 13 (16.0%) were considered life-threatening.

Is Intentional product misuse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOCLOPRAMIDE. However, 81 reports have been filed with the FAERS database.

What Other Side Effects Does METOCLOPRAMIDE Cause?

Nausea (1,080) Drug ineffective (927) Off label use (926) Drug hypersensitivity (751) Vomiting (672) Dyspnoea (525) Headache (499) Diarrhoea (481) Hypersensitivity (473) Tardive dyskinesia (465)

What Other Drugs Cause Intentional product misuse?

ETANERCEPT (3,992) PREGABALIN (3,731) BUDESONIDE\FORMOTEROL (3,399) ACETAMINOPHEN (2,924) ESOMEPRAZOLE (2,852) MINOXIDIL (2,418) TOFACITINIB (2,331) CINACALCET (2,092) QUETIAPINE (1,855) ALPRAZOLAM (1,709)

Which METOCLOPRAMIDE Alternatives Have Lower Intentional product misuse Risk?

METOCLOPRAMIDE vs METOLAZONE METOCLOPRAMIDE vs METOPIMAZINE METOCLOPRAMIDE vs METOPROLOL METOCLOPRAMIDE vs METRELEPTIN METOCLOPRAMIDE vs METRONIDAZOLE

Related Pages

METOCLOPRAMIDE Full Profile All Intentional product misuse Reports All Drugs Causing Intentional product misuse METOCLOPRAMIDE Demographics